|20K Industries||United States, Vienna, Virginia|
|Alive Ideas||France, Ile-de-France, Paris|
|Careismatic Brands||California, Chatsworth, United States|
|Cube Infrastructure Managers||Luxembourg, Luxembourg|
|Dakota Capital Partners||Dallas, Texas, United States|
|Danisco Venture||Copenhagen, Denmark, Hovedstaden|
|MidMark Capital||Morristown, New Jersey, United States|
|NDI Healthcare Fund||Cleveland, Ohio, United States|
|Oqu Wenhua||China, Shanghai|
|Qingrong Investment Management||Beijing, Beijing, China|
|RWE||Essen, Germany, Nordrhein-Westfalen|
|Shanghai Deyue Touzi Youxian Gongsi||China, Shanghai|
|TCL Capital||China, Guangdong, Shenzhen|
|Wuxi Lejin Touzi Guanli Co., Ltd||China, Jiangsu, Wuxi Shi|
|Xinzhi Touzi||China, Jiangsu, Taizhou|
|$1M||12 Nov 2021||-|
|$65M||15 Sep 2021||(Old) Ottawa, Ontario, Canada|
|$17M||22 Apr 2021||Toronto, Ontario, Canada|
Guardian Optical Technologies
|$2M||12 Nov 2018||Tel Aviv District|
– Medchart announced that it has raised $17M in Seed and Series A funding led by Crosslink Capital and Golden Ventures, with additional funds from Vast Ventures, Union Ventures, iGan Partners, Stanford Law School, and Nas, an original backer.
– The company will apply the current investment to accelerate product innovation and hire new talent to meet the widespread demand for businesses to get patient-authorized health information.
– Medchart squarely addresses one of the slowest, most tedious, and fractured processes: getting patient health records for common business tasks.
– Medchart lets businesses easily, securely, and cost-effectively access and exchange patient-authorized digital health information for everything from life sciences real-world evidence or insurance underwriting to legal claims.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.